- Endometrial cancer risk and survival by tumor MMR status
-
Nagle CM, O'Mara TA, Tan Y, Buchanan D, Obermair A, Blomfield , Quinn MA, Webb PM, Spurdle AB, on behalf of the Australian Endometrial Cancer Study Group
- KMID: 2409940
- J Gynecol Oncol.
- 2018 May;29(3):e39.
- doi: 10.3802/jgo.2018.29.e39
OBJECTIVE: The risk of developing endometrial cancer (EC) and/or survival following a diagnosis of EC might differ by tumor DNA mismatch repair (MMR) status. We assessed the association between tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020
-
Obermair A, Beale P, Scott CL, Beshay V, Kichenadasse G, Simcock B, Nicklin J, Lee YC, Cohen P, Meniawy T
- KMID: 2526284
- J Gynecol Oncol.
- 2021 Nov;32(6):e95.
- doi: 10.3802/jgo.2021.32.e95
Epithelial ovarian cancer (EOC) is among the top ten causes of cancer deaths worldwide, and is one of the most lethal gynecological malignancies in high income countries, with incidence and... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility-sparing treatment in early endometrial cancer: current state and future strategies
-
Obermair A, Baxter E, Brennan DJ, McAlpine JN, Muellerer JJ, Amant F, van Gent MDJM, Coleman RL, Westin SN, Yates MS, Krakstad C, Janda M
- KMID: 2505031
- Obstet Gynecol Sci.
- 2020 Jul;63(4):417-431.
- doi: 10.5468/ogs.19169
Endometrial cancer (EC) is the fifth most common cancer in women worldwide. Global estimates show rising incidence rates in both developed and developing countries. Most women are diagnosed postmenopausal, but... -
- CITED
-
- Close
- SHARE
-
- Close
